谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

242PDInitial results of a phase 1 dose expansion cohort of M6620 (formerly VX-970), an ATR inhibitor, in combination with cisplatin in patients with advanced triple-negative breast cancer NCT02157792)

Ml Telli,S. Lord,Em Dean,V. Abramson,H-T Arkenau,C. Becerra,Sm Tolaney,R. Tang,M.S. Penney,J. Pollard,G. Conboy,Sz Fields, G. Shapiro

ANNALS OF ONCOLOGY（2017）

引用 3|浏览39
暂无评分
关键词
atr inhibitor,cisplatin,dose expansion cohort,triple-negative
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要